Influence of size and duration of gynecomastia on its response to treatment with tamoxifen;Terapia médica de la ginecomastia con tamoxifeno. Influencia del volumen y duración de la ginecomastia en el resultado terapéutico

Revista Medica de Chile

Volumn 135, Issue 12, 2007, Pages 1558-1565

  Devoto C, Enzo ^a,d   Madariaga A, Marcia ^b   Lioi C, Ximena ^a   Mardones, Nelly ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Servicio de Psiquiatría Hospital Clínico Dr Félix Búlnes   (Chile)

^d NONE   (Chile)

Author keywords

Androgen antagonists; Estrogen antagonists; Gynecomastia; Tamoxifen

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; FOLLOW UP; GYNECOMASTIA; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; ESTROGEN ANTAGONISTS; FOLLOW-UP STUDIES; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; TAMOXIFEN; TREATMENT OUTCOME;

EID: 40549135301     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. HERSHKOVITZ E, LEIBERMAN E. Gynecomastia: A Review. The Endocrinologist 2002; 12: 321-32.
2. MATHUR R, BRAUNSTEIN G. Gynecomastia: Pathomechanisms and treatment strategies. Horm Res 1997; 48: 95-102.
3. DEVOTO E, MADARIAGA M, ARAVENA L, LIOI X. Etiología de la ginecomastia. Importancia de no subdiagnosticar una ginecomastia patológica. Rev Méd Chile 2007; 135: 189-97.
4. GABRILOVE J, SHARMA D, WOTIZ H, DORFMAN R. Feminizing adrenocortical tumors in the male, a review of 52 cases including a case report. Medicine 1965; 44: 37-79.
5. MINEUR P, DE COOMAN S, HUSTIN J, VERHOEVEN G, DE HERTOGH R. Feminizing Testicular Leydig Cell Tumor: Hormonal profile before and after unilateral orchidectomy. J Clin Endocrinol Metab 1987; 64: 686-91.
6. SMYTH C, BREMNER W. Klinefelter Syndrome. Arch Intern Med 1998; 158: 1309-14.
7. NYDICK M, BUSTOS J, DALE J, RAWSON R. Gynecomastia in adolescent boys. JAMA 196; 178: 449-54.
8. COLOMBO-BENKMANN M, BUSE B, STERN J, HERFARTH C. Indications for and results of surgical therapy for male Gynecomastia. Am J Surg 1999; 178: 60-3.
9. MACGREGOR J, JORDAN C. Basic guide to the mechanisms of Antiestrogen action. Pharmacological Reviews 1998; 50: 151-96.
10. DAVIES C, ARRIAGADA R, ZIEGLER A, PERALTA O. Duración del tratamiento adyuvante con Tamoxifeno en el cáncer de mama operable. Rev Méd Chile 1998; 126: 210-7.
11. STEPANAS A, BURNET R, HARDING P, WISE P. Clomiphene in the treatment of pubertal-adolescent Gynecomastia: A preliminary report. J Pediatr 1977; 90: 651-3.
12. LE ROIT D, SOBEL R, GLICK S. The effect of clomiphene citrate on pubertal Gynaecomastia. Acta Endocrinol 1980; 95: 177-80.
13. PLOURDE P, KULIN H, SANTNER S. Clomiphene in the treatment of adolescent Gynecomastia. Am J Dis Child 1983; 137: 1080-2.
14. DEVOTO E, ARAVENA L, MADARIAGA M. Utilidad de la terapia antirreceptor de hormonas sexuales en la mujer y en el varón. Rev SOGIA 1995; 2: 16-22.
15. JEFFERYS DB. Painful Gynaecomastia treated with Tamoxifen. Br Med J 1979; 1: 1119-20.
16. PARKER L, GRAY D, LAI M, LEVIN E. Treatment of Gynecomastia with Tamoxifen: A double-blind crossover study. Metabolism 1986; 35: 705-8.
17. SERELS S AND MELMAN A. Tamoxifen as treatment for Gynecomastia and mastodynia resulting from hormonal deprivation. J Urol 1998; 159: 1309.
18. MCDERMOTT MT, HOFELDT FD, KIDD GS. Tamoxifen therapy for painful idiopathic Gynecomastia. South Med J 1990; 83: 1283-5.
19. NIEWOEHNER C, NUTTAL F. gynecomastia in a hospitalized male population. Am J Med 1984; 77: 633-8.
20. TING A, CHOW L, LEUNG Y. Comparison of Tamoxifen with Danazol in the management of idiopathic Gynecomastia. Am Surg 2000; 66: 38-40.
21. ALAGARATNAM TT. Idiopathic Gynecomastia treated with Tamoxifen: A preliminary report. Clin Ther 1987; 9: 483-7.
22. KONIG R, SCHONBERGER W, NEUMANN P, BENES P, GRIMM W. Treatment of marked Gynecomastia in puberty with Tamoxifen. Klin Padiatr 1987; 199: 389-91.
23. KHAN HN, RAMPAUL R, BLAMEY RW. Management of physiological gynaecomastia with tamoxifen. The Breast 2004; 13: 61-5.
24. LAWRENCE S, FAUGHT A, VETHAMUTHU J, LAWSON M. Benefical Effects of Raloxifene and Tamoxifen in the Treatment of Pubertal Gynecomastia. J Pediatr 2004; 145: 71-6.
25. PLOURDE P-V, REITER EO, HANN-CHANG JOU, DESROCHERS P, RUBIN S, BERCU B ET AL. Safety an Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab 2004; 89: 4428-33.
26. SIMPSON E, MISSO M, HEWITT K, HILL R, BOON W, JONES M ET AL. Estrogen - the Good, the Bad, and the unexpected. Endocrine Reviews 2005; 26: 322-30.
27. RIEPE F, BAUS I, WIEST S, KRONE N, SIPPELL W, PARTSCH C-J. Treatment of Pubertal Gynecomastia with the Specific aromatase Inhibitor Anastrozole. Horm Res 2004; 62: 113-8.
28. BOCCARDO F, RUBAGOTTI A, BATTAGLIA M, DI TONNO P, SELVAGGI F, CONTI G ET AL. Evaluation of Tamoxifen and Anastrazole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Cancer. J Clin Oncology 2005; 23: 808-15.
29. SALTZSTEIN D, SIEBER P, MORRIS T, GALLO J. Prevention and management of bicalutamide - induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrazole. Prostate Cancer and Prostatic Diseases 2005; 8: 75-83.
30. STAIMAN V, LOWE F. Tamoxifen for Flutamide/ Finasteride induced Gynecomastia. Urol 1997; 50: 929-33.
31. BRAUNSTEIN G. Gynecomastia. N Engl J Med 1993; 328: 490-5.
32. NICOLIS G, MODLINGER R, GABRILOVE JL. A study of the histopathology of human Gynecomastia. J Clin Endocrinol Metab 1971; 32: 173-8.